Difficulty: Medium
Average Score: 62%
Practice
Which of the following types of translocation of childhood AML that typically associated with granulocytic sarcoma mass?
Correct answer
A
Rationale
In childhood Acute Myeloid Leukemia (AML), the translocation inv(16) is typically associated with granulocytic sarcoma mass. This translocation involves inversion of chromosome 16, leading to the fusion of the CBFB gene with the MYH11 gene. This fusion gene is known as CBFB-MYH11 and is a characteristic feature of AML with inv(16), also known as AML-M4eo subtype.
Option A, inv(16), is the correct answer because it specifically relates to the question about translocations associated with granulocytic sarcoma mass in childhood AML.
Option B, t(8;21), is associated with AML-M2 subtype and the fusion of RUNX1-RUNX1T1 genes, not granulocytic sarcoma mass.
Option C, t(6;9), is linked to AML with inv(3), not granulocytic sarcoma mass.
Option D, inv(3), is associated with AML-M4 subtype and the rearrangement of the RPN1 gene, not granulocytic sarcoma mass.
Understanding these translocations is crucial in diagnosing and managing pediatric AML. Educators should emphasize the significance of genetic abnormalities in AML, as they influence prognosis and treatment decisions. Clinical correlation of genetic findings with disease presentation is essential for providing optimal care to pediatric patients with AML.
Option A, inv(16), is the correct answer because it specifically relates to the question about translocations associated with granulocytic sarcoma mass in childhood AML.
Option B, t(8;21), is associated with AML-M2 subtype and the fusion of RUNX1-RUNX1T1 genes, not granulocytic sarcoma mass.
Option C, t(6;9), is linked to AML with inv(3), not granulocytic sarcoma mass.
Option D, inv(3), is associated with AML-M4 subtype and the rearrangement of the RPN1 gene, not granulocytic sarcoma mass.
Understanding these translocations is crucial in diagnosing and managing pediatric AML. Educators should emphasize the significance of genetic abnormalities in AML, as they influence prognosis and treatment decisions. Clinical correlation of genetic findings with disease presentation is essential for providing optimal care to pediatric patients with AML.